2OA phase Ib/II study of APG-115 in combination with pembrolizumab in patients with unresectable or metastatic melanomas or advanced solid tumors. (27th February 2019) - Tolcher, A W; Fang, D D; Li, Y; Tang, Y; Ji, J; Wang, H; Karim, R; Rosas, C; Huang, Y; Zhai, Y